Clinicopathological study of pulmonary extranodal nature killer/T-cell lymphoma, nasal type and literature review

被引:17
作者
Ding, Wenshuang [1 ]
Wang, Jianchao [1 ]
Zhao, Sha [1 ]
Yang, Qunpei [1 ]
Sun, Hong [1 ]
Yan, Jiaqi [1 ]
Gao, Limin [1 ]
Yao, Wenqing [1 ]
Zhang, Wenyan [1 ]
Liu, Weiping [1 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Pathol, Chengdu 610041, Sichuan, Peoples R China
关键词
Pulmonary; Lymphoma; Clinical pathology; Extranodal NK/T-cell lymphoma; nasal type; Immunophenotype; T-CELL; (NK)/T-CELL LYMPHOMA; CLINICAL-FEATURES; STAGE IE; NK; EXPRESSION; CLASSIFICATION; CHEMOTHERAPY; EXPERIENCE; LEUKEMIA;
D O I
10.1016/j.prp.2015.04.002
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objectives: Malignant tumors of the lung are predominantly derived from epithelial tissue, such as squamous cell carcinoma and adenocarcinoma, while pulmonary lymphatic and hematopoietic tumor is relatively rare. Extranodal NK/T-cell lymphoma (ENKTL), nasal type, originates in nasal and extra-nasal sites anatomically. This distinct non-Hodgkin lymphoma is endemic and is characterized by a highly aggressive clinical course and dismal survival outcome. Extra-nasal ENKTL, especially pulmonary ENKTL, is rare compared with nasal type ENKTL and has received relatively little attention. Therefore, this study was conducted to assess the clinicopathological features of pulmonary ENKTL and to promote awareness of this malignancy. Materials and methods: All cases of ENKTL, nasal type diagnosed from January 2008 to June 2014 in our institution were collected, and those with pulmonary involvement were selected for further study. The eligible cases were analyzed retrospectively: medical recordings, imaging manifestations, pathological features, immunophenotypes, EBER1/2 hybridizations in situ and other related literatures were reviewed. Results and conclusions: A total of 1105 cases were diagnosed as ENKTL, nasal type, in this period, and 8 cases (7.2 parts per thousand) had lung involvement. Seven cases had core biopsy, and for 1 case, a resected tissue specimen was available. The group was composed of 6 men and 2 women (gender ratio 3:1) with ages ranging from 19 to 44 (average age of 33.5) years. In this group, 2 cases were secondary and 5 cases were primary. The clinical symptoms and computed tomography (CT) manifestations were nonspecific. Histologically, the neoplasms presented angiocentric and angiodestructive growth patterns with different degrees of inflammatory response and necrosis. The neoplastic cell sizes were heterogeneous with spectra of small to large or mixed-composition types. For the immunophenotypes, all cases were positive for CD3 epsilon and cytotoxic granule (granzyme B or TIA-1). The positive ratios of CD56 and CD30 were 6/8 and 4/5 respectively. All 8 cases showed positive in situ hybridization for Epstein-Barr virus-encoded small RNA (EBER). TCR-gamma gene rearrangement was tested in 4 cases, and only 1 of these cases was monoclonal. Laboratory testing demonstrated that the whole blood was decreased while the average level of LDH was elevated. Six bone marrow biopsy specimens were negative and showed no neoplastic cells infiltration. For treatment, 4 individuals accepted chemotherapy and 1 patient underwent localized tumor resection surgery. The follow-up information was available for 6 patients, 1 of whom was alive and the others cases survived shortly between 20 days and 4 months. ENKTL, nasal type of lung is very rare, and the diagnosis is challenging due to nonspecific clinical symptoms and imaging results. The diagnosis of pulmonary ENKTL should be based on comprehensive clinical, imaging, histopathological and molecular examination. More effective treatment strategies are required for this disease. (C) 2015 Elsevier GmbH. All rights reserved.
引用
收藏
页码:544 / 549
页数:6
相关论文
共 31 条
[1]   NASAL LYMPHOMAS IN PERU - HIGH-INCIDENCE OF T-CELL IMMUNOPHENOTYPE AND EPSTEIN-BARR-VIRUS INFECTION [J].
ARBER, DA ;
WEISS, LM ;
ALBUJAR, PF ;
CHEN, YY ;
JAFFE, ES .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1993, 17 (04) :392-399
[2]   Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project [J].
Au, Wing-yan ;
Weisenburger, Dennis D. ;
Intragumtornchai, Tanin ;
Nakamura, Shigeo ;
Kim, Won-Seog ;
Sng, Ivy ;
Vose, Julie ;
Armitage, James O. ;
Liang, Raymond .
BLOOD, 2009, 113 (17) :3931-3937
[3]   Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years [J].
Au, WY ;
Ma, SY ;
Chim, CS ;
Choy, C ;
Loong, F ;
Lie, AKW ;
Lam, CCK ;
Leung, AYH ;
Tse, E ;
Yau, CC ;
Liang, R ;
Kwong, YL .
ANNALS OF ONCOLOGY, 2005, 16 (02) :206-214
[4]  
Chan J K, 1998, Anat Pathol, V3, P77
[5]   Comparison of primary and secondary cutaneous CD56+NK/T cell lymphomas [J].
Chang, SE ;
Yoon, GS ;
Huh, J ;
Choi, JH ;
Sung, KJ ;
Moon, KC ;
Koh, JK .
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2002, 10 (02) :163-170
[6]   A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy [J].
Fox, Christopher P. ;
Haigh, Tracey A. ;
Taylor, Graham S. ;
Long, Heather M. ;
Lee, Steven P. ;
Shannon-Lowe, Claire ;
O'Connor, Simon ;
Bollard, Catherine M. ;
Iqbal, Javeed ;
Chan, Wing C. ;
Rickinson, Alan B. ;
Bell, Andrew I. ;
Rowe, Martin .
BLOOD, 2010, 116 (19) :3695-3704
[7]   The World Health Organization classification of malignant lymphomas in Japan: Incidence of recently recognized entities [J].
Fujita, M ;
Yamashiro, K ;
Ichinohasama, R ;
Nakamura, N ;
Abe, M ;
Wakasa, H ;
Kojima, M ;
Motoori, T ;
Izumo, T ;
Tamaru, J ;
Mikata, A ;
Takeuchi, K ;
Kakiuchi, C ;
Mori, S ;
Matsuno, Y ;
Nakamura, S ;
Yatabe, Y ;
Ichimura, K ;
Suchi, T ;
Tajima, K ;
Mori, N ;
Takasaki, K ;
Tsurumi, K ;
Takami, T ;
Haga, H ;
Sakurai, T ;
Yamabe, H ;
Kobashi, Y ;
Ohsawa, M ;
Kanno, H ;
Aozasa, K ;
Nakamine, H ;
Yoshino, T ;
Akagi, T ;
Sasaki, N ;
Namba, K ;
Agatsuma, Y ;
Iwata, K ;
Suzumiya, J ;
Ohshima, K ;
Kikuchi, M ;
Takeshita, M ;
Hasui, K ;
Sato, E ;
Sueyoshi, K ;
Tokunaga, M .
PATHOLOGY INTERNATIONAL, 2000, 50 (09) :696-702
[8]   A prospective study of 728 cases of non-Hodgkin lymphoma from a single laboratory in Shanghai, China [J].
Gross, Sherilyn A. ;
Zhu, Xiongzeng ;
Bao, Liming ;
Ryder, John ;
Le, Anh ;
Chen, Yan ;
Wang, Xiao Qin ;
Irons, Richard D. .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 88 (02) :165-173
[9]   Clinicopathologic and Molecular Features of 122 Brazilian Cases of Nodal and Extranodal NK/T-Cell Lymphoma, Nasal Type, With EBV Subtyping Analysis [J].
Gualco, Gabriela ;
Domeny-Duarte, Pollyanna ;
Chioato, Lucimara ;
Barber, Glen ;
Natkunam, Yasodha ;
Bacchi, Carlos E. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2011, 35 (08) :1195-1203
[10]   Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: Elucidating the significance of systemic chemotherapy [J].
Guo, Ye ;
Lu, Jiade J. ;
Ma, Xuejun ;
Wang, Biyun ;
Hong, Xiaonan ;
Li, Xiaoqiu ;
Li, Jin .
ORAL ONCOLOGY, 2008, 44 (01) :23-30